News search related to the stock GENZYME CORPORATI (ordered by date):

Cancer Nanomedicine Market Dynamics Analysis, Production, Supply and Demand, Covered in the Latest Research 2021-2028  Digital Journal ImmunoGen Appoints Tracey L. McCain, Esq. to Its Board of Directors  Yahoo Finance Cogent Biosciences Provides Corporate Updates and Reports Third Quarter 2021 Financial Results  PRNewswire Viscosupplementation Market Size 2021, Share Estimation, Trend Analysis, Industry Growth Rate, Company Profiles with Strategies, Global Sales and Revenues, Future Demands, Production-Scenario and Supply Forecast 2026  Taiwan News Movers & Shakers, July 9 | BioSpace  BioSpace Worldwide Whole Genome and Exome Sequencing Industry to 2026 - Featuring 10x Genomics, Abbott Diagnostics and Agilent Among Others  PRNewswire Clinical Diagnostics Market is Going to Boom with Siemens Healthcare, Sonic Healthcare, Charles River Laboratories ? UK Parents Lounge  UK Parents Lounge Genzyme Ireland sees 50% growth in profits to ?65.2m  The Irish Times Aesthetic Fillers Market is Expected to Reach USD 4.6 Billion by 2027 - AllTheResearch  GlobeNewswire Harvard Business School's Baker Library Announces New Collection: John Hawkins Research Interviews about Henri Termeer, Longtime Chairman, CEO, and President of Genzyme Corporation - News  Harvard Business School Joseph Arron marches to the beat of his own drum at 23andMe; Ex-Voyager CFO joins Sek Kathiresan at Verve Therapeutics  Endpoints News ReForm Biologics Announces Corporate Reorganization  Business Wire Vericel Expands Executive Leadership Team and Announces Appointment of Patrick Fowler as Senior Vice President, Corporate Development and Strategy  Yahoo Finance Gaucher Disease Treatment Market 2021 ? 2028 | Industry In-depth Analysis By Players Genzyme Corporation, Pfizer, Inc., Shire Human Genetics Therapies, Inc.  Medgadget The Petri Dish: Former Genzyme CFO joins biologics startup - Boston Business Journal  Boston Business Journal FDA Approves New Treatment for Pompe Disease | FDA  FDA.gov Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right  FierceBiotech Sanofi is betting big on mRNA vaccines after Moderna, Pfizer see success with COVID-19 shots  The Boston Globe Sanofi approaches Genzyme for acquisition: sources  Reuters Sanofi-aventis buys Genzyme for $20 billion - Feb. 16, 2011  CNNMoney Graft Versus Host Disease Treatment Market Report 2021-2028 | Size, Share, Growth Factors, Restraining Factors, Revenue, Competitive Landscape, Forecast Analysis  Yahoo Finance Potential SRT for Neuronopathic Gaucher Shows Efficacy in Early Study  Gaucher Disease News Sanofi announces settlement agreement related to Contingent Value Rights (CVRs) Litigation  GlobeNewswire Sanofi-Aventis Completes Acquisition of Genzyme Corporation  PR Newswire M&A Objection Lawsuits and Claims for Inadequate Consideration: A ?Bumpy? Road for D&O Insurers  JD Supra Gemini Therapeutics Announces Appointment of Georges Gemayel, Ph.D. as Chair of Board of Directors  Business Wire Henri A. Termeer Square Officially Dedicated in Cambridge  Business Wire Titan Medical Expands Senior Leadership Team  Business Wire Adagio Therapeutics Appoints Leading Pharmaceutical and Regulatory Executives to its Board of Directors  Business Wire VBI Vaccines Appoints Linda Bain to Board of Directors  Business Wire Exclusive: Relational analysis puts Genzyme value at $93/shr  Reuters MNOV: Milestone Payments from Legacy Gene Therapy Assets...  Yahoo Finance